ProGoods Medicamentos Especiais
ProGoods Medicamentos Especiais, with the slogan "Medicamentos especiais a favor da saúde," was founded in 2016. The company's main focus is to promote access to specialized medicines that contribute to the health and quality of life of its patients.
The company operates in the Health Care and Pharmaceutical industries and specializes in the distribution and delivery of high-complexity, high-cost specialized medications, particularly focusing on chemotherapy drugs. Additionally, it provides value-added services such as distribution, e-commerce, import advisory for specialized medications, and quotation via judicial demand.
ProGoods Medicamentos Especiais prides itself on offering the trust and quality of the best laboratories in Brazil and globally. It ensures the entire medication distribution process, including humanized customer service, timely and secure nationwide delivery, as well as pre- and post-sales support.
The company holds certifications from key Brazilian health institutions such as Anvisa, CRF, COVISA, and GAFO, as well as international organizations including the FDA (United States), EMA (Europe), CDSCO (India), and TITCK (Turkey).
ProGoods Medicamentos Especiais has not disclosed its last investment or investors. With its commitment to improving access to specialized medications and its extensive network of certifications, the company presents an intriguing opportunity for potential investors in the health care and pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for ProGoods Medicamentos Especiais.